勘误：ESHRE指南：体外受精/卵胞浆内单精子注射的卵巢刺激。
Erratum: ESHRE guideline: ovarian stimulation for IVF/ICSI.
作者信息
Bosch Ernesto, Broer Simone, Griesinger Georg, Grynberg Michael, Humaidan Peter, Kolibianakis Estratios, Kunicki Michal, Marca Antonio La, Lainas George, Clef Nathalie Le, Massin Nathalie, Mastenbroek Sebastiaan, Polyzos Nikolaos, Sunkara Sesh Kamal, Timeva Tanya, Töyli Mira, Urbancsek Janos, Vermeulen Nathalie, Broekmans Frank
机构信息
IVI-RMS Valencia, Valencia, Spain.
Department of Reproductive Medicine and Gynecology, University Medical Center Utrecht, The Netherlands.
出版信息
Hum Reprod Open. 2020 Dec 29;2020(4):hoaa067. doi: 10.1093/hropen/hoaa067. eCollection 2020.
Abstract
[This corrects the article DOI: 10.1093/hropen/hoaa009.][This corrects the article DOI: 10.1093/hropen/hoaa009.].
摘要
[本文更正文章DOI：10.1093/hropen/hoaa009。][本文更正文章DOI：10.1093/hropen/hoaa009。]
相似文献
1
Erratum: ESHRE guideline: ovarian stimulation for IVF/ICSI.勘误：ESHRE指南：体外受精/卵胞浆内单精子注射的卵巢刺激。
Hum Reprod Open. 2020 Dec 29;2020(4):hoaa067. doi: 10.1093/hropen/hoaa067. eCollection 2020.
2
Erratum: Increased blood pressure and impaired endothelial function after accelerated growth in IVF/ICSI children.勘误：体外受精/卵胞浆内单精子注射（IVF/ICSI）儿童生长加速后血压升高及内皮功能受损。
Hum Reprod Open. 2020 Jan 31;2020(1):hoaa004. doi: 10.1093/hropen/hoaa004. eCollection 2020.
3
Questionable recommendation for LPS for IVF/ICSI in ESHRE guideline 2019: ovarian stimulation for IVF/ICSI.2019年ESHRE指南中关于体外受精/卵胞浆内单精子注射使用脂多糖的可疑推荐：体外受精/卵胞浆内单精子注射的卵巢刺激。
Hum Reprod Open. 2021 Mar 3;2021(1):hoab005. doi: 10.1093/hropen/hoab005. eCollection 2021.
4
Reply: Questionable recommendation for LPS for IVF/ICSI in ESHRE guideline 2019: ovarian stimulation for IVF/ICSI.回复：2019年欧洲人类生殖与胚胎学会（ESHRE）指南中关于体外受精/卵胞浆内单精子注射（IVF/ICSI）使用脂多糖（LPS）的可疑推荐：IVF/ICSI的卵巢刺激。
Hum Reprod Open. 2021 Mar 3;2021(1):hoab006. doi: 10.1093/hropen/hoab006. eCollection 2021.
5
ICSI does not improve reproductive outcomes in autologous ovarian response cycles with non-male factor subfertility.ICSI 并不能改善非男性因素导致的卵巢反应不良的自身免疫性不育患者的妊娠结局。
Hum Reprod. 2020 Mar 27;35(3):583-594. doi: 10.1093/humrep/dez301.
6
Erratum to: IVF, from the past to the future: the inheritance of the Capri Workshop Group.勘误：《体外受精：从过去到未来——卡普里研讨会小组的传承》
Hum Reprod Open. 2020 Nov 16;2020(4):hoaa051. doi: 10.1093/hropen/hoaa051. eCollection 2020.
7
Corrigendum. ART in Europe, 2015: results generated from European registries by ESHRE.勘误。2015年欧洲辅助生殖技术：欧洲人类生殖与胚胎学会（ESHRE）欧洲登记处得出的结果。
Hum Reprod Open. 2020 Sep 22;2020(3):hoaa038. doi: 10.1093/hropen/hoaa038. eCollection 2020.
8
Erratum: An independent validation study of three single nucleotide polymorphisms at the sex hormone-binding globulin locus for testosterone levels identified by genome-wide association studies.勘误：一项对全基因组关联研究鉴定出的性激素结合球蛋白基因座上三个单核苷酸多态性与睾酮水平关系的独立验证研究。
Hum Reprod Open. 2017 Jun 14;2017(1):hox005. doi: 10.1093/hropen/hox005. eCollection 2017.
9
ART in Europe, 2014: results generated from European registries by ESHRE: The European IVF-monitoring Consortium (EIM) for the European Society of Human Reproduction and Embryology (ESHRE).ART 在欧洲，2014：ESHRE 欧洲注册处产生的结果：欧洲人类生殖与胚胎学学会（ESHRE）的欧洲 IVF 监测联合组织（EIM）。
Hum Reprod. 2018 Sep 1;33(9):1586-1601. doi: 10.1093/humrep/dey242.
10
Assisted reproductive technology in Europe, 2011: results generated from European registers by ESHRE.2011年欧洲辅助生殖技术：欧洲人类生殖与胚胎学会（ESHRE）欧洲登记处发布的结果
Hum Reprod. 2016 Feb;31(2):233-48. doi: 10.1093/humrep/dev319. Epub 2016 Jan 5.
引用本文的文献
1
Effect of GnRH antagonist pretreatment before controlled ovarian stimulation in antagonist protocol for infertile women with PCOS undergoing IVF/ICSI: A propensity score matching analysis.GnRH拮抗剂预处理在多囊卵巢综合征不孕女性体外受精/卵胞浆内单精子注射拮抗剂方案控制性卵巢刺激中的作用：一项倾向评分匹配分析
Medicine (Baltimore). 2025 Jun 27;104(26):e42965. doi: 10.1097/MD.0000000000042965.
2
Visualization analysis of ovarian hyperstimulation syndrome based on bibliometrics.基于文献计量学的卵巢过度刺激综合征可视化分析
Medicine (Baltimore). 2025 May 16;104(20):e42342. doi: 10.1097/MD.0000000000042342.
3
Optimal embryo management strategies for patients undergoing antagonist protocols in IVF treatment.体外受精治疗中接受拮抗剂方案患者的最佳胚胎管理策略
J Assist Reprod Genet. 2025 Mar;42(3):827-838. doi: 10.1007/s10815-024-03365-6. Epub 2024 Dec 31.
4
Development and validation of a gonadotropin dose selection model for optimized ovarian stimulation in IVF/ICSI: an individual participant data meta-analysis.体外受精/卵胞浆内单精子注射中优化卵巢刺激的促性腺激素剂量选择模型的开发与验证：一项个体参与者数据荟萃分析
Hum Reprod Update. 2025 Mar 1;31(2):116-132. doi: 10.1093/humupd/dmae032.
5
Effectiveness of oestrogen pretreatment in patients with expected poor ovarian response (POSEIDON groups 3 and 4) undergoing GnRH antagonist protocol: study protocol for a randomised controlled trial.预期卵巢反应不良（POSEIDON 分组 3 和 4）的患者接受 GnRH 拮抗剂方案时雌激素预处理的效果：一项随机对照试验的研究方案。
BMJ Open. 2023 Aug 9;13(8):e069840. doi: 10.1136/bmjopen-2022-069840.
6
Optimizing estradiol level for gonadotrophin-releasing hormone antagonist initiation among patients with simple tubal factor infertility.优化单纯输卵管因素不孕患者促性腺激素释放激素拮抗剂起始时的雌二醇水平。
Front Endocrinol (Lausanne). 2022 Sep 9;13:915923. doi: 10.3389/fendo.2022.915923. eCollection 2022.
7
The effect of flexible low-dose GnRH antagonist on pregnancy outcome in the fresh embryo transfer cycle of IVF-ET: a randomized controlled trial.灵活的低剂量 GnRH 拮抗剂对 IVF-ET 新鲜胚胎移植周期妊娠结局的影响：一项随机对照试验。
Reprod Biol Endocrinol. 2022 Mar 22;20(1):55. doi: 10.1186/s12958-022-00927-0.
8
Variants Ala307Ala and Ser680Ser of 307 and 680 FSHr polymorphisms negatively influence on assisted reproductive techniques outcome and determine high probability of non-pregnancy in Caucasian patients.307 和 680 FSHr 多态性的 Ala307Ala 和 Ser680Ser 变体对辅助生殖技术结局有负面影响，并确定高加索患者妊娠概率低。
J Assist Reprod Genet. 2021 Oct;38(10):2769-2779. doi: 10.1007/s10815-021-02276-0. Epub 2021 Aug 3.
9
The Role of Traditional Chinese Formula Ding-Kun Pill (DKP) in Expected Poor Ovarian Response Women (POSEIDON Group 4) Undergoing Fertilization-Embryo Transfer: A Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial.定坤丹对卵巢低反应患者体外受精-胚胎移植结局的影响：多中心、随机、双盲、安慰剂对照临床研究。
Front Endocrinol (Lausanne). 2021 Jun 17;12:675997. doi: 10.3389/fendo.2021.675997. eCollection 2021.
10
Questionable recommendation for LPS for IVF/ICSI in ESHRE guideline 2019: ovarian stimulation for IVF/ICSI.2019年ESHRE指南中关于体外受精/卵胞浆内单精子注射使用脂多糖的可疑推荐：体外受精/卵胞浆内单精子注射的卵巢刺激。
Hum Reprod Open. 2021 Mar 3;2021(1):hoab005. doi: 10.1093/hropen/hoab005. eCollection 2021.
Zotero 插件